Identifying Replicable Healthcare Models with Significant Social Benefit

This is the first in-depth global study that identifies healthcare innovations in developing countries with the potential to be replicated to increase access to affordable medicine.

On behalf of GlaxoSmithKline (GSK) in 2013, we produced this report that assesses over 900 healthcare programmes for their suitability for investment to scale up and replicate elsewhere. It identifies significant opportunities for commercial organisations to establish strategic partnerships with a number of promising healthcare delivery models in order to drive scale, profitability and impact.

Press:

  *In 2017 The International Centre for Social Franchising (ICSF) became Spring Impact. This report was created under our old      branding and name.

Press enter or esc to cancel